Insulin aspart, recombinant Subcutaneous and Liposyn III
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Liposyn III and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: fat emulsion
Brand name: Omegaven, Clinolipid, Intralipid, Nutrilipid, SMOFlipid
Synonyms: Fat Emulsion (Fish Oil Based)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Liposyn II
- Insulin aspart, recombinant Subcutaneous-LiproZonePak
- Insulin aspart, recombinant Subcutaneous-Liptruzet
- Insulin aspart, recombinant Subcutaneous-Liptruzet Tablets
- Insulin aspart, recombinant Subcutaneous-LiQsorb coenzyme Q-10
- Insulin aspart, recombinant Subcutaneous-Liquadd
- Liposyn III-Insulin degludec
- Liposyn III-Insulin Degludec (U-100) Prefilled Pens
- Liposyn III-Insulin Degludec (U-100) Vials
- Liposyn III-Insulin Degludec (U-200) Prefilled Pens
- Liposyn III-Insulin degludec and liraglutide
- Liposyn III-Insulin degludec and liraglutide Subcutaneous